Health Services Research & Development

• Iaccarino JM, Steiling KA, Wiener RS. Lung Cancer Screening in a Safety-Net Hospital: Implications of Screening a Real-World Population versus the National Lung Screening Trial. Annals of the American Thoracic Society. 2018 Dec 1; 15(12):1493-1495.
• Thomas KS, Boyd E, Mariotto AB, Penn DC, Barrett MJ, Warren JL. New Opportunities for Cancer Health Services Research: Linking the SEER-Medicare Data to the Nursing Home Minimum Data Set. Medical care. 2018 Dec 1; 56(12):e90-e96.
• Haverhals LM, Manheim CE, Mor V, Ersek M, Kinosian B, Lorenz KA, Faricy-Anderson KE, Gidwani-Marszowski RA, Levy C. The experience of providing hospice care concurrent with cancer treatment in the VA. Supportive Care in Cancer : Official Journal of The Multinational Association of Supportive Care in Cancer. 2018 Nov 22.
• Chioreso C, Del Vecchio N, Schweizer ML, Schlichting J, Gribovskaja-Rupp I, Charlton ME. Association Between Hospital and Surgeon Volume and Rectal Cancer Surgery Outcomes in Patients With Rectal Cancer Treated Since 2000: Systematic Literature Review and Meta-analysis. Diseases of The Colon and Rectum. 2018 Nov 1; 61(11):1320-1332.
• Nguyen MM, Martinez JA, Hsu CH, Sokoloff M, Krouse RS, Gibson BA, Nagle RB, Parnes HL, Cordova C, Chow HS. Bioactivity and prostate tissue distribution of metformin in a preprostatectomy prostate cancer cohort. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP). 2018 Nov 1; 27(6):557-562.

» View more Citations

• Men Using VA More Likely to Receive Appropriate Prostate Cancer Imaging Tests Compared to Those Using Medicare
  This study sought to assess the association between the quality of healthcare within VA vs. Medicare, by comparing rates of guideline-concordant and guideline-discordant staging imaging among patients with newly diagnosed prostate cancer utilizing VA services only, Medicare only, or a combination of the two. Findings showed that among men with low-risk prostate cancer, the VA-only and VA-Medicare ...
  
  Date: August 17, 2018
• Increase in Conservative Management of Veterans with Low-Risk Prostate Cancer Suggests Reduction in Over-Treatment
  Investigators assessed utilization of conservative management among Veterans by examining treatment patterns for Veterans diagnosed with low-risk prostate cancer. Untreated Veterans were classified as receiving conservative management through either active surveillance (> 2 PSAs and 1 biopsy within 2 years after diagnosis) or watchful waiting. Findings showed that utilization of conservative manag...
  
  Date: June 5, 2018
• VA’s Lower Intensity Treatment of Kidney Failure – Compared to Medicare – Does Not Result in Associated Increased Mortality
  This study compared the initiation of dialysis and mortality among Veterans ages 67 and older with incident kidney failure who received pre-end-stage renal disease (ESRD) care in fee-for-service Medicare vs. VA between January 2008 and December 2011. Findings showed that Veterans who received pre-ESRD nephrology care in Medicare received dialysis more often than Veterans who received VA care (82% ...
  
  Date: April 9, 2018
• Evidence Review Identifies Modest Mortality Disparities among Racial and Ethnic Minority Groups in VA Healthcare
  To support VA’s efforts to better understand the scale and determinants of disparities in racial and ethnic mortality – and to develop interventions to reduce disparities, investigators from the VA Evidence-based Synthesis Program (ESP) Coordinating Center in Portland, OR conducted an evidence review of mortality disparities specific to VA. Findings showed that although VA’s equal access healthcar...
  
  Date: March 1, 2018
• Veterans with Cancer Received Higher Quality, Lower Intensity End-of Life Care in VA Compared to Medicare
  This study evaluated the quality of end-of-life cancer care provided by Fee-for-Service (FFS) Medicare and VA, using well-accepted quality-of-care metrics. Findings showed that Veterans treated under FFS Medicare were more likely to get unduly intensive healthcare at end-of-life compared to those treated by VA. For example, Medicare-reliant Veterans were significantly more likely to receive chemot...
  
  Date: January 1, 2018

» View more Publication Briefs

» View more Studies

• Management Briefs eBrief-no63 - Treatment of Metastatic Non-Small Cell Lung Cancer
  ...and Cost-Effectiveness: Treatment of Metastatic Non-Small Cell Lung Cancer Most patients with lung cancer are diagnosed when the cancer is already...
  
  
• Management Briefs eBrief-no70 - Effects of Caregiver Interventions on Outcomes for Memory-related Disorders or Cancer
  ...Management Briefs eBrief-no70 Effects of Caregiver Interventions on Outcomes for Memory-related Disorders or Cancer Management eBrief no. 70...
  
  
• Management Briefs eBrief-no87 - A Systematic Review: Shared Decision Making for Cancer Screening
  ...all Management eBriefs Issue 87 October 2014 A Systematic Review: Shared Decision Making for Cancer Screening Patient decisions about cancer screening...
  
  
• The Effects of Shared Decision Making on Cancer Screening
  ...Most organizations publishing clinical practice guidelines for cancer screening now recommend that preference-sensitive cancer screening decisions...
  
  
• Treatment of Metastatic Non-Small Cell Lung Cancer: A Systematic Review of Comparative Effectiveness and Cost-Effectiveness
  ...and more effective treatments. Most patients with lung cancer are diagnosed when the cancer is already advanced (stage IIIB or IV), and they are...
  
  

» View more Publications

» View more Cyberseminars

Videos

There are currently no videos for this topic.

Podcasts

There are currently no podcasts for this topic.

Other Resources

• Visit the Office of Research and Development website to learn more about all VA cancer research milestones and other research service investigations.
• Access the Veterans Health Library cancer information section.
• Visit the National Institute’s of Health National Cancer Institute website.